Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.